Latest profit margin for Eastwood Bio-Medical Canada: -74.09% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jul 2024
Trailing 12 months ending Jul 2024
As of the most recent data (July 2024), EBM.V shows a profit margin of -74.09%. That compares with -36.14% in the prior-year period — down 105.0% year over year. That is below the sector sector average of 13.4%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, EBM.V's profit margin is now -74.09% (was -36.14%) — a 105.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Eastwood Bio-Medical Canada is outperforming or lagging.
The its sector sector average profit margin is about 13.4%. Eastwood Bio-Medical Canada is at -74.09%, which is lower that average. That is roughly 652.7% below the sector mean. Use the comparison chart on this page to see how EBM.V stacks up against individual peers as well.
That compares with -36.14% in the prior-year period — down 105.0% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Eastwood Bio-Medical Canada with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Eastwood Bio-Medical Canada's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -74.09%) with ownership activity and broader fundamentals.